September 26, 2020 1:04 AM

Latest:

39 US States Running Out of Money to Pay Their Bills as Pandemic Spending Creates Massive Deficits
Liberals Propose Increasing COVID-19 Benefits, Extending Government Emergency Spending Powers in Throne Speech
Mission Ready Secures Additional $58.5 Million In Orders Under $435 Million Government Contract
Canadian Home Prices Expected to Drop in 2021 as Pandemic Concerns Continue to Mount
Aurania Resources Extends Silver-Gold Target By 15 Kilometres

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Briefing
- Cannabis
- Commentary
- Education
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Psychedelics
- Resources
- Technology
Cannabis
Technology
Company Profiles
Resources
About
Contact Us
Advertise With Us

Psychedelics

Mind Cure Receives Health Canada Approval For Sale Of Moonbeam Mushroom Products

September 23, 2020 8:33 AMSeptember 23, 2020 8:33 AM Jay Lutz 0 Comments Mind Cure Health

Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its functional mushroom products to begin

Briefing Psychedelics

Mind Medicine Applies To List On The Nasdaq

September 21, 2020 7:53 AMSeptember 21, 2020 7:53 AM Jay Lutz 0 Comments Mind Medicine

Mind Medicine (NEO: MMED) this morning announced that it has submitted an application to uplist its stateside cross-listing to that

Briefing News Psychedelics

Mind Cure: Mental Health Focused Firm To Commence Trading Monday

September 20, 2020 9:00 AMSeptember 19, 2020 11:46 PM Jay Lutz 0 Comments Mind Cure Health

Mind Cure Health (CSE: MCUR) is the latest issue to hit the Canadian Securities Exchange with the company set to

Briefing Psychedelics

Mind Medicine: Canaccord Genuity Initiates Coverage With C$1.75 Price Target

September 16, 2020 4:15 PMSeptember 16, 2020 3:16 PM Justin Young 0 Comments Analyst Estimate, Mind Medicine, MindMed

Yesterday, Canaccord initiated coverage on Mind Medicine (NEO: MMED) with a Speculative Buy rating and a C$1.75 price target. Canaccord’s

Briefing Psychedelics Technology

Revive Therapeutics To Conduct Phase 1 Clinical Trials For Psilocybin

September 2, 2020 8:43 AMSeptember 2, 2020 8:45 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) is driving forward with its psilocybin studies. The company announced this morning that it has entered

Briefing Psychedelics

Compass Pathways, Psilocybin Research Firm, Files For Nasdaq IPO

August 29, 2020 11:43 AMAugust 29, 2020 12:14 AM Jay Lutz 0 Comments Compass Pathways

It appears that some authenticity and validation might be coming to the psychedelics space. Compass Pathways, a UK startup focused

Biotech Briefing Psychedelics

Revive Submits for IRB Approval; Expects to Enroll Patients in September

August 26, 2020 10:07 AMAugust 26, 2020 10:07 AM Small Cap Steve 0 Comments COVID-19, Revive Therapeutics

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial protocol to their independent Institutional

Briefing Psychedelics Technology

Revive Therapeutics Receives First Prototype of Orally Dissolvable Psilocybin Film Strips

August 11, 2020 8:53 AMAugust 11, 2020 8:53 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that it has received the first set of orally dissolvable thin film strips,

Briefing Psychedelics Technology

Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments

August 5, 2020 9:50 AMAugust 5, 2020 9:51 AM Jay Lutz 0 Comments Coronavirus, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that on the heels of receiving FDA approval for phase 3 clinical trials

Briefing News Psychedelics

Champignon Brands Files Required Disclosures With Exchange, Resumption Of Trading In Hands Of BCSC

July 24, 2020 5:33 PMJuly 24, 2020 5:33 PM Jay Lutz 1 Comment Champignon Brands

Champignon Brands (CSE: SHRM) has completed the regulatory filings required as per the review previously initiated by the British Columbia

← Previous

Briefings

Briefing Macro

39 US States Running Out of Money to Pay Their Bills as Pandemic Spending Creates Massive Deficits

September 25, 2020 3:39 PM Hermina Paull 0

It appears that the US federal government is not the only one amassing extraordinary amounts of debt in response to

Briefing Macro

Liberals Propose Increasing COVID-19 Benefits, Extending Government Emergency Spending Powers in Throne Speech

September 25, 2020 2:07 PM Hermina Paull 0

Briefing Industrials

Mission Ready Secures Additional $58.5 Million In Orders Under $435 Million Government Contract

September 25, 2020 12:52 PM Jay Lutz 0

Briefing Macro

Canadian Home Prices Expected to Drop in 2021 as Pandemic Concerns Continue to Mount

September 25, 2020 11:01 AM Hermina Paull 0

Briefing Resources

Our first recurring guest on our Spotlight Series is that of Chris Naprawa, whom is now the Chairman of Khiron

News

Briefing News Technology

Vegaste Tech To Acquire Bloombox Club, Enter European Market

September 24, 2020 11:39 AM Jay Lutz 0

Vegaste Technologies Corp (CSE: VEGA) has entered into a letter of intent to acquire Bloombox Club Limited. Bloombox is a

Briefing News Resources

West Red Lake Hits 5.91 G/T Gold Over 6.0 Metres At NT Zone

September 24, 2020 10:54 AM Jay Lutz 0

Briefing News Technology

Datametrex Secures Services Agreement Valued At An Estimated $20 Million For Supply Of COVID-19 Test Kits

September 24, 2020 9:36 AM Jay Lutz 0

Briefing News Resources

Kingman Minerals Acquires Option For Additional Mohave County Property

September 24, 2020 9:13 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Need some freelance work done? We’re experienced in many forms of writing, including press releases. Shoot us an email & let’s chat!